Synthetic Drug Awareness Act of 2018

United States115th CongressHR-449House of Representatives
Updated: Jun 13, 2018

Summary

Synthetic Drug Awareness Act of 2017 This bill requires the Surgeon General to report to Congress on the public health effects of the increased use since January 2010 by individuals who are 12 to 18 years old of drugs developed and manufactured to avoid control under the Controlled Substances Act (e.g., synthetic marijuana, also known as "spice," and synthetic amphetamines, also known as "bath salts").

Bill texts

Available versions
View official text

3 versions available

All available records shown.

Timeline

  1. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

  2. Motion to reconsider laid on the table Agreed to without objection. (text: CR H5029)

    House of Representatives

  3. The title of the measure was amended. Agreed to without objection.

    House of Representatives

  4. Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate